Dicerna Pharmaceuticals Inc (DRNA) has 106 open-market insider trades by 25 insiders since 2014. The most active filer is Bob D. Brown, VP.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Peter Kolchinsky | Dir | — | 3 | $85.2M | 2019-12-02 |
| Adam Koppel | Dir | — | 2 | $60.4M | 2021-12-28 |
| Bain Capital Life Sciences Partners, LP | Dir10% Owner | — | 2 | $40.5M | 2019-11-19 |
| Capital Investors Ii L.p. Brookside | 10% | — | 1 | $29.2M | 2014-03-18 |
| Brian K. Halak | Dir | — | 3 | $25.0M | 2018-11-06 |
| BCIP Life Sciences Associates, LP | Dir10% Owner | — | 1 | $20.0M | 2019-05-29 |
| RA Capital Management, LLC via Rajeev M. Shah | 10% | — | 1 | $15.0M | 2017-12-18 |
| James E. Flynn | 10% | — | 1 | $15.0M | 2014-02-04 |
| Douglas Fambrough | CEOPres | — | 7 | $11.3M | 2021-12-28 |
| Bob D. Brown | VP | — | 29 | $9.3M | 2021-12-28 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Bob D. Brown | VP | Sell | $1.9M | 2021-11-18 |
| Ling Zeng | CLO | Sell | $29K | 2021-09-17 |
| Bob D. Brown | VP | Sell | $448K | 2021-09-17 |
| Shreeram Aradhye | EVP & Chief Medical Officer | Sell | $44K | 2021-09-17 |
| Douglas Fambrough | CEO & President | Buy | $111K | 2021-08-10 |
| Marc D. Kozin | Director | Buy | $71K | 2021-08-10 |
Companies that share insiders with DRNA, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Bob D. Brown | VP | Sell | $621K | 2021-08-02 |
| James B. Weissman | COO & VP | Sell | $1.2M | 2021-07-06 |
| Bob D. Brown | VP | Sell | $581K | 2021-07-01 |
| Regina M. Paglia | Chief Human Resources Officer | Sell | $38K | 2021-06-25 |
| Regina M. Paglia | CHRO | Sell | $1.4M | 2021-06-22 |
| Regina M. Paglia | CHRO | Sell | $620K | 2021-06-17 |
| Regina M. Paglia | CHRO | Sell | $2.2M | 2021-06-16 |
| Bob D. Brown | VP | Sell | $340K | 2021-06-11 |
| Robert D. Ciappenelli | CCO | Sell | $1.1M | 2021-06-11 |